Monopar Therapeutics Inc. (MNPR)

NASDAQ: MNPR · Real-Time Price · USD

108.35

-6.31 (-5.50%)

At close: Jul 31, 2026, 4:00 PM EDT

108.25

-0.10 (-0.09%)

After-hours: Jul 31, 2026, 7:42 PM EDT

Monopar Therapeutics Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Assets

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Equivalents	52.54	61.83	45.82	7.27	8.19	20.3
Short-Term Investments	84.95	78.57	14.4	-	4.93	-
Cash & Short-Term Investments	137.49	140.4	60.21	7.27	13.12	20.3
Cash Growth	152.04%	133.17%	728.67%	-44.62%	-35.38%	21.31%
Other Current Assets	0.25	0.06	0.08	0.07	0.05	0.22
Total Current Assets	137.74	140.46	60.29	7.33	13.17	20.52
Net Property, Plant & Equipment	0.24	0.25	-	0.01	0.06	-
Total Assets	137.98	140.72	60.29	7.35	13.23	20.52

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Accounts Payable	2.46	2.74	2.25	1.76	3.13	1.58
Accrued Expenses	-	-	3	-	-	-
Total Current Liabilities	2.46	2.74	5.25	1.76	3.13	1.58
Long-Term Leases	0.13	0.15	-	-	0.01	-
Total Long-Term Liabilities	0.13	0.15	-	-	0.01	-
Total Liabilities	2.59	2.89	5.25	1.76	3.14	1.58

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Common Stock	0.01	0.01	0.01	0	0.01	0.01
Additional Paid-in Capital	228.69	227.2	130.79	65.81	61.87	60.22
Accumulated Other Comprehensive Income	0.1	0.13	0.04	-0.01	0.01	-0
Retained Earnings	-93.4	-89.51	-75.79	-60.21	-51.8	-41.29
Shareholders' Equity	135.39	137.83	55.04	5.59	10.09	18.94
Total Liabilities & Equity	137.98	140.72	60.29	7.35	13.23	20.52

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Total Debt	0.13	0.15	0	0	0.01	0
Net Cash (Debt)	137.36	140.24	60.21	7.27	13.11	20.3
Net Cash Growth	151.80%	132.92%	728.67%	-44.58%	-35.42%	21.31%
Net Cash Per Share	17.61	18.92	15.89	2.63	5.16	8.14
Book Value	135.39	137.83	55.04	5.59	10.09	18.94
Book Value Per Share	17.36	18.60	14.52	2.02	3.97	7.59
Tangible Book Value	135.39	137.83	55.04	5.59	10.09	18.94
Tangible Book Value Per Share	17.36	18.60	14.52	2.02	3.97	7.59

SEC Filings: 10-K · 10-Q